Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2-locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study | ANNALS OF ONCOLOGY |